Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [12757]

Bladder cancer - When to use chemotherapy

Bladder cancer - When to use chemotherapy

Study demonstrates efficacy of new treatment for neurofibromatosis type 1-related tumours

Study demonstrates efficacy of new treatment for neurofibromatosis type 1-related tumours

$FDA approves crizotinib for children and young adults with relapsed or refractory, systemic anaplastic large cell lymphoma$

FDA approves crizotinib for children and young adults with relapsed or refractory, systemic anaplastic large cell...

Triggering tumour antiviral immune response in triple negative breast cancer

Triggering tumour antiviral immune response in triple negative breast cancer

Tool that predicts if chemotherapy will produce debilitating side effects in older adults

Tool that predicts if chemotherapy will produce debilitating side effects in older adults

An unexpected, and novel, target for prostate cancer - our biological clock

An unexpected, and novel, target for prostate cancer - our biological clock

Inpatient mammograms can reduce disparities in breast cancer screening rates

Inpatient mammograms can reduce disparities in breast cancer screening rates

Study shows sharp decline in cancer screenings, diagnoses during the first COVID-19 surge

Study shows sharp decline in cancer screenings, diagnoses during the first COVID-19 surge

The cancer microbiome reveals which bacteria live in tumours

The cancer microbiome reveals which bacteria live in tumours

Immune system killer cells controlled by circadian rhythms

Immune system killer cells controlled by circadian rhythms

More from ecancer